PubRank

Study of a Dietary Supplement for Reflux During Sleep (SXDSFRS)

Clinical Trial ID NCT02274636

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02274636

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997 8.51
2 Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013 6.82
3 Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005 3.86
4 American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008 2.79
5 Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984 2.68
6 Acid-reflux disorders. N Engl J Med 1994 2.24
7 Predictors of heartburn during sleep in a large prospective cohort study. Chest 2005 2.11
8 Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol 2009 1.76
9 A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol 2009 1.71
10 Acid neutralizing capacity of human saliva. Gastroenterology 1982 1.32
11 Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 1987 1.22
12 Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol 2004 1.22
13 Reflux disease: the disorder of the third millennium. Eur J Gastroenterol Hepatol 2001 1.19
14 Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil 2010 1.10
15 The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000 1.10
16 Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009 1.10
17 A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2008 0.99
18 New developments in extraesophageal reflux disease. Gastroenterol Hepatol (N Y) 2012 0.98
19 Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009 0.98
20 Reflux revisited: advancing the role of pepsin. Int J Otolaryngol 2011 0.95
21 Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol 2012 0.95
22 Review article: supra-oesophageal manifestations of gastro-oesophageal reflux disease and the role of night-time gastro-oesophageal reflux. Aliment Pharmacol Ther 2004 0.94
23 Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007 0.92
24 Gastroesophageal reflux, dental erosion, and halitosis in epidemiological surveys: a systematic review. Eur J Gastroenterol Hepatol 2013 0.89
25 Medical treatments of GERD: the old and new. Gastroenterol Clin North Am 2013 0.88
26 Gastroesophageal reflux disease: Important considerations for the older patients. World J Gastrointest Endosc 2010 0.87
27 Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life 2010 0.87
28 Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease. Am J Gastroenterol 2001 0.87
29 Evidence for decreased salivary function in patients with reflux esophagitis. Digestion 1999 0.86
30 Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population. J Gastroenterol 2008 0.86
31 Oral manifestations of gastroesophageal reflux disease. J Gastroenterol Hepatol 2012 0.85
32 Salivary parameters and teeth erosions in patients with gastroesophageal reflux disease. Arq Gastroenterol 2012 0.85
33 Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age Ageing 2000 0.83
34 Oral symptoms including dental erosion in gastroesophageal reflux disease are associated with decreased salivary flow volume and swallowing function. J Gastroenterol 2011 0.81
35 Salivary egf concentration in adults with reflux chronic laryngitis before and after treatment: preliminary results. Braz J Otorhinolaryngol 2007 0.81
36 Modulation of salivation and heartburn in response to the site of acid infusion in the human oesophagus. Aliment Pharmacol Ther 2010 0.80
37 Effect of age on immunoglobulin content and volume of human labial gland saliva. J Dent Res 1992 0.79
38 Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. Clin Ther 2010 0.79
39 Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study. Eur J Gastroenterol Hepatol 2009 0.78
40 Is pepsin detected in the saliva of patients who experience pharyngeal reflux? Hippokratia 2007 0.77
41 Use of a mucoadhesive disk for relief of dry mouth: a randomized, double-masked, controlled crossover study. J Am Dent Assoc 2010 0.76
42 Laboratory based investigations for diagnosing gastroesophageal reflux disease. Best Pract Res Clin Gastroenterol 2010 0.76
43 XyliMelts time-release adhering discs for night-time oral dryness. Int J Dent Hyg 2011 0.75
44 Dental erosion and salivary flow rate in cerebral palsy individuals with gastroesophageal reflux. J Oral Pathol Med 2011 0.75
Next 100